Ávila-Gómez, P.; Pérez-Mato, M.; Hervella, P.; Dopico-López, A.; Silva-Candal, A.d.; Bugallo-Casal, A.; López-Amoedo, S.; Candamo-Lourido, M.; Sobrino, T.; Iglesias-Rey, R.;
et al. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke. J. Clin. Med. 2022, 11, 949.
https://doi.org/10.3390/jcm11040949
AMA Style
Ávila-Gómez P, Pérez-Mato M, Hervella P, Dopico-López A, Silva-Candal Ad, Bugallo-Casal A, López-Amoedo S, Candamo-Lourido M, Sobrino T, Iglesias-Rey R,
et al. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke. Journal of Clinical Medicine. 2022; 11(4):949.
https://doi.org/10.3390/jcm11040949
Chicago/Turabian Style
Ávila-Gómez, Paulo, María Pérez-Mato, Pablo Hervella, Antonio Dopico-López, Andrés da Silva-Candal, Ana Bugallo-Casal, Sonia López-Amoedo, María Candamo-Lourido, Tomás Sobrino, Ramón Iglesias-Rey,
and et al. 2022. "Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke" Journal of Clinical Medicine 11, no. 4: 949.
https://doi.org/10.3390/jcm11040949
APA Style
Ávila-Gómez, P., Pérez-Mato, M., Hervella, P., Dopico-López, A., Silva-Candal, A. d., Bugallo-Casal, A., López-Amoedo, S., Candamo-Lourido, M., Sobrino, T., Iglesias-Rey, R., Castillo, J., & Campos, F.
(2022). Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke. Journal of Clinical Medicine, 11(4), 949.
https://doi.org/10.3390/jcm11040949
